Himalaya Nutravedics India Ltd is currently trading at 173.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Himalaya Nutravedics India Limited manufactures, markets and distributes classical and proprietary Ayurvedic formulations, nutraceuticals, and third-party contract-manufactured products across multiple dosage forms from its Hyderabad facility. H1 FY27 revenue increased 35.8% year-on-year to ₹2,739.8 lakhs, while EBITDA grew 51.1% to ₹567.2 lakhs. EBITDA margin expanded 210 basis points to 20.7%, indicating improved operating leverage despite a single-facility manufacturing footprint. Own-branded products became the larger revenue contributor at 54.7% in H1 FY27, marking a significant transition from the company’s earlier dependence on third-party manufacturing and potentially improving control over customer relationships, pricing, and long-term brand economics. The company’s distribution network now covers 20 states and one Union Territory, although Kerala remains a major anchor market contributing 47.7% of H1 FY27 revenue. Geographic diversification is progressing, but regional concentration remains material. IPO proceeds are intended to support ₹750 lakh of branding and digital marketing, working capital, D2C, marketplace, and quick-commerce initiatives. However, operating cash flow remained negative at ₹65.5 lakhs, while inventories and receivables continued rising, requiring close execution and liquidity monitoring.

Over the past 52 weeks, Himalaya Nutravedics India Ltd has traded between a low of ₹109.95 and a high of ₹188.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Himalaya Nutravedics India Ltd has a market capitalization of approximately 151.47. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Himalaya Nutravedics India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 18.08 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 151.47 Cr, Himalaya Nutravedics India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Himalaya Nutravedics India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Himalaya Nutravedics India Ltd is 18.08. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Himalaya Nutravedics reported Rs 25.84 crore of net cash from financing activities in H1 FY27, lifting cash and cash equivalents to Rs 26.62 crore. Its presentation also states that an IPO-led equity capital infusion increased the capital base during the period.

Himalaya Nutravedics generated 54.7% of H1 FY27 revenue from its own-brand business. Third-party contract manufacturing contributed the remaining 45.3%, making own brands the larger of its two reported segments.

Himalaya Nutravedics India reported net profit of ₹4.4 crore for the half year ended September 30, 2026. The company said this represented year-on-year growth of 33.3%.